Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease

Arlene B. Chapman, James E. Bost, Vicente Torres, Lisa Guay-Woodford, Kyongtae Ty Bae, Douglas Landsittel, Jie Li, Bernard Francis King, Diego Martin, Louis H. Wetzel, Mark E. Lockhart, Peter C Harris, Marva Moxey-Mims, Mike Flessner, William M. Bennett, Jared J. Grantham

Research output: Contribution to journalArticle

198 Citations (Scopus)

Abstract

Background and objectives: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by increased total kidney volume (TKV) and renal failure. This study aimed to determine if height-adjusted TKV (htTKV) predicts the onset of renal insufficiency. Design, setting, participants, & measurements: This prospective, observational, longitudinal, multicenter study included 241 adults with ADPKD and preserved renal function. Magnetic resonance imaging and iothalamate clearance were used to measure htTKV and GFR, respectively. The association between baseline htTKV and the attainment of stage 3 CKD (GFR<60 ml/min per 1.73 m 2) during follow-up was determined. Results: After a mean follow-up of 7.9 years, stage 3 CKD was attained in 30.7% of the enrollees. Using baseline htTKV, negative correlations with GFR increased from -0.22 at baseline to -0.65 at year 8. In multivariable analysis, a baseline htTKV increase of 100 cc/m significantly predicted the development of CKD within 8 years with an odds ratio of 1.48 (95% confidence interval: 1.29, 1.70). In receiver operator characteristic curve analysis, baseline htTKV of 600 cc/m most accurately defined the risk of developing stage 3 CKD within 8 years with an area under the curve of 0.84 (95% confidence interval: 0.79, 0.90). htTKVwas a better predictor than baseline age, serum creatinine, BUN, urinary albumin, or monocyte chemotactic protein-1 excretion (P<0.05). Conclusions: Baseline htTKV ≥600 cc/m predicted the risk of developing renal insufficiency in ADPKD patients at high risk for renal disease progressionwithin 8 years of follow-up, qualifying htTKV as a prognostic biomarker in ADPKD.

Original languageEnglish (US)
Pages (from-to)479-486
Number of pages8
JournalClinical Journal of the American Society of Nephrology
Volume7
Issue number3
DOIs
StatePublished - Mar 1 2012

Fingerprint

Autosomal Dominant Polycystic Kidney
Renal Insufficiency
Kidney
Iothalamic Acid
Confidence Intervals
Chemokine CCL2
Blood Urea Nitrogen
Multicenter Studies
Area Under Curve
Longitudinal Studies
Albumins
Creatinine
Biomarkers
Odds Ratio
Magnetic Resonance Imaging
Serum

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. / Chapman, Arlene B.; Bost, James E.; Torres, Vicente; Guay-Woodford, Lisa; Bae, Kyongtae Ty; Landsittel, Douglas; Li, Jie; King, Bernard Francis; Martin, Diego; Wetzel, Louis H.; Lockhart, Mark E.; Harris, Peter C; Moxey-Mims, Marva; Flessner, Mike; Bennett, William M.; Grantham, Jared J.

In: Clinical Journal of the American Society of Nephrology, Vol. 7, No. 3, 01.03.2012, p. 479-486.

Research output: Contribution to journalArticle

Chapman, AB, Bost, JE, Torres, V, Guay-Woodford, L, Bae, KT, Landsittel, D, Li, J, King, BF, Martin, D, Wetzel, LH, Lockhart, ME, Harris, PC, Moxey-Mims, M, Flessner, M, Bennett, WM & Grantham, JJ 2012, 'Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease', Clinical Journal of the American Society of Nephrology, vol. 7, no. 3, pp. 479-486. https://doi.org/10.2215/CJN.09500911
Chapman, Arlene B. ; Bost, James E. ; Torres, Vicente ; Guay-Woodford, Lisa ; Bae, Kyongtae Ty ; Landsittel, Douglas ; Li, Jie ; King, Bernard Francis ; Martin, Diego ; Wetzel, Louis H. ; Lockhart, Mark E. ; Harris, Peter C ; Moxey-Mims, Marva ; Flessner, Mike ; Bennett, William M. ; Grantham, Jared J. / Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. In: Clinical Journal of the American Society of Nephrology. 2012 ; Vol. 7, No. 3. pp. 479-486.
@article{7d7a9d5d9d6f437d9eabfeb65077f805,
title = "Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease",
abstract = "Background and objectives: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by increased total kidney volume (TKV) and renal failure. This study aimed to determine if height-adjusted TKV (htTKV) predicts the onset of renal insufficiency. Design, setting, participants, & measurements: This prospective, observational, longitudinal, multicenter study included 241 adults with ADPKD and preserved renal function. Magnetic resonance imaging and iothalamate clearance were used to measure htTKV and GFR, respectively. The association between baseline htTKV and the attainment of stage 3 CKD (GFR<60 ml/min per 1.73 m 2) during follow-up was determined. Results: After a mean follow-up of 7.9 years, stage 3 CKD was attained in 30.7{\%} of the enrollees. Using baseline htTKV, negative correlations with GFR increased from -0.22 at baseline to -0.65 at year 8. In multivariable analysis, a baseline htTKV increase of 100 cc/m significantly predicted the development of CKD within 8 years with an odds ratio of 1.48 (95{\%} confidence interval: 1.29, 1.70). In receiver operator characteristic curve analysis, baseline htTKV of 600 cc/m most accurately defined the risk of developing stage 3 CKD within 8 years with an area under the curve of 0.84 (95{\%} confidence interval: 0.79, 0.90). htTKVwas a better predictor than baseline age, serum creatinine, BUN, urinary albumin, or monocyte chemotactic protein-1 excretion (P<0.05). Conclusions: Baseline htTKV ≥600 cc/m predicted the risk of developing renal insufficiency in ADPKD patients at high risk for renal disease progressionwithin 8 years of follow-up, qualifying htTKV as a prognostic biomarker in ADPKD.",
author = "Chapman, {Arlene B.} and Bost, {James E.} and Vicente Torres and Lisa Guay-Woodford and Bae, {Kyongtae Ty} and Douglas Landsittel and Jie Li and King, {Bernard Francis} and Diego Martin and Wetzel, {Louis H.} and Lockhart, {Mark E.} and Harris, {Peter C} and Marva Moxey-Mims and Mike Flessner and Bennett, {William M.} and Grantham, {Jared J.}",
year = "2012",
month = "3",
day = "1",
doi = "10.2215/CJN.09500911",
language = "English (US)",
volume = "7",
pages = "479--486",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "3",

}

TY - JOUR

T1 - Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease

AU - Chapman, Arlene B.

AU - Bost, James E.

AU - Torres, Vicente

AU - Guay-Woodford, Lisa

AU - Bae, Kyongtae Ty

AU - Landsittel, Douglas

AU - Li, Jie

AU - King, Bernard Francis

AU - Martin, Diego

AU - Wetzel, Louis H.

AU - Lockhart, Mark E.

AU - Harris, Peter C

AU - Moxey-Mims, Marva

AU - Flessner, Mike

AU - Bennett, William M.

AU - Grantham, Jared J.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Background and objectives: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by increased total kidney volume (TKV) and renal failure. This study aimed to determine if height-adjusted TKV (htTKV) predicts the onset of renal insufficiency. Design, setting, participants, & measurements: This prospective, observational, longitudinal, multicenter study included 241 adults with ADPKD and preserved renal function. Magnetic resonance imaging and iothalamate clearance were used to measure htTKV and GFR, respectively. The association between baseline htTKV and the attainment of stage 3 CKD (GFR<60 ml/min per 1.73 m 2) during follow-up was determined. Results: After a mean follow-up of 7.9 years, stage 3 CKD was attained in 30.7% of the enrollees. Using baseline htTKV, negative correlations with GFR increased from -0.22 at baseline to -0.65 at year 8. In multivariable analysis, a baseline htTKV increase of 100 cc/m significantly predicted the development of CKD within 8 years with an odds ratio of 1.48 (95% confidence interval: 1.29, 1.70). In receiver operator characteristic curve analysis, baseline htTKV of 600 cc/m most accurately defined the risk of developing stage 3 CKD within 8 years with an area under the curve of 0.84 (95% confidence interval: 0.79, 0.90). htTKVwas a better predictor than baseline age, serum creatinine, BUN, urinary albumin, or monocyte chemotactic protein-1 excretion (P<0.05). Conclusions: Baseline htTKV ≥600 cc/m predicted the risk of developing renal insufficiency in ADPKD patients at high risk for renal disease progressionwithin 8 years of follow-up, qualifying htTKV as a prognostic biomarker in ADPKD.

AB - Background and objectives: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by increased total kidney volume (TKV) and renal failure. This study aimed to determine if height-adjusted TKV (htTKV) predicts the onset of renal insufficiency. Design, setting, participants, & measurements: This prospective, observational, longitudinal, multicenter study included 241 adults with ADPKD and preserved renal function. Magnetic resonance imaging and iothalamate clearance were used to measure htTKV and GFR, respectively. The association between baseline htTKV and the attainment of stage 3 CKD (GFR<60 ml/min per 1.73 m 2) during follow-up was determined. Results: After a mean follow-up of 7.9 years, stage 3 CKD was attained in 30.7% of the enrollees. Using baseline htTKV, negative correlations with GFR increased from -0.22 at baseline to -0.65 at year 8. In multivariable analysis, a baseline htTKV increase of 100 cc/m significantly predicted the development of CKD within 8 years with an odds ratio of 1.48 (95% confidence interval: 1.29, 1.70). In receiver operator characteristic curve analysis, baseline htTKV of 600 cc/m most accurately defined the risk of developing stage 3 CKD within 8 years with an area under the curve of 0.84 (95% confidence interval: 0.79, 0.90). htTKVwas a better predictor than baseline age, serum creatinine, BUN, urinary albumin, or monocyte chemotactic protein-1 excretion (P<0.05). Conclusions: Baseline htTKV ≥600 cc/m predicted the risk of developing renal insufficiency in ADPKD patients at high risk for renal disease progressionwithin 8 years of follow-up, qualifying htTKV as a prognostic biomarker in ADPKD.

UR - http://www.scopus.com/inward/record.url?scp=84863230673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863230673&partnerID=8YFLogxK

U2 - 10.2215/CJN.09500911

DO - 10.2215/CJN.09500911

M3 - Article

C2 - 22344503

AN - SCOPUS:84863230673

VL - 7

SP - 479

EP - 486

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 3

ER -